Skip to content
  • Sunday, 26 July 2026
  • 3:21 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough Discovery of Fam102a Protein as Key Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment
Stem Cell & Regenerative Medicine

Breakthrough Discovery of Fam102a Protein as Key Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Jun 1, 2026 0

In a landmark study published in Nature Communications on January 2, 2025, a multidisciplinary team of researchers led by Professor…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as Molecular Exercise Sensor to Combat Osteoporosis and Age-Related Bone Loss

Dwi Wanna May 27, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna May 24, 2026 0

A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as the Key Exercise Sensor in Bone Maintenance and Potential Target for Osteoporosis Treatment

Dwi Wanna May 19, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 17, 2026 0

In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Novel Bone Remodeling Factor Offers New Pathway for Osteoporosis Treatment

Dwi Wanna May 9, 2026 0

In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 as the Biological Exercise Sensor for Bone Health Paving the Way for Novel Osteoporosis Treatments

Dwi Wanna May 5, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 1, 2026 0

In a landmark study that could redefine the clinical approach to metabolic bone diseases, a research team led by Professor…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as Bone Exercise Sensor Opening New Frontiers for Osteoporosis Treatment

Dwi Wanna Apr 28, 2026 0

In a landmark study that bridges the gap between physical mechanobiology and molecular pharmacology, researchers from the LKS Faculty of…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Apr 23, 2026 0

In a landmark study that promises to redefine the landscape of musculoskeletal medicine, researchers at the Institute of Science Tokyo…

Read More

Posts pagination

1 2 3
Cave of Whispers: Ancient Owl’s Larder Becomes Bee Nursery, Unveiling Remarkable Paleontological DiscoveryThe Remarkable Resilience of Giant Trees: How Foliage and Vascular Systems Adapt to Survive DroughtInnovative Gene Therapy Targets Chronic Pain Circuits Without Addiction Risk in Landmark Preclinical StudyResearchers Identify Experimental Strategy to Boost MeCP2 Protein Levels as Potential Therapy for Rett Syndrome
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ